Pathogen Partnerships or Power Struggles? Pseudomonas aeruginosa, and Staphylococcus aureus Dynamics in Cystic Fibrosis
Current Microbiology · 2025
DOI: 10.1007/s00284-025-04167-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Microbiology, 2025. Verfasst von Neveen M Saleh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Egyptian Drug Authority (Former National Organization for Drug Control and Research (NODCAR)), Giza, Egypt. salehneveen@y…. Hauptthemen laut MEDLINE: Cystic Fibrosis, Pseudomonas aeruginosa, Staphylococcus aureus, Pseudomonas Infections. Die Arbeit nennt 50 Literaturangaben.
Abstract (Originalsprache)
Cystic fibrosis (CF) is a polymicrobial infection characterized by interactions among various bacterial species that affect one another's cohabitation. The investigation of interspecies interactions in dual infections is essential to understand their reaction in the environment better and assist in the development of treatment regimens and innovative disease control approaches. Our hypothesis posits that co-infection interactions promote the adaptation of Staphylococcus aureus and Pseudomonas aeruginosa, potentially leading to synergistic action. To explore this, we examined dual-species interactions in co-isolated pairs of these organisms from Egyptian CF patients using laboratory media and artificial sputum media (ASM). Based on demographic data, 82 collected bacterial isolates from single, dual, and triple cultures were identified from 50 enrolled patients. In the interaction of the pairs in mimic media, P. aeruginosa exo-products significantly enhanced the biofilm formation and growth of S. aureus. Conversely, S. aureus did not inhibit P. aeruginosa biofilm formation. Furthermore, the biofilm mode of dual-organism growth provides protection in the CF context, as bacterial biofilms can withstand much higher antimicrobial levels compared to planktonically grown bacteria. Additionally, key biofilm genes regulated by quorum sensing were differentially expressed in both species in an isolate-dependent manner, highlighting their significant role in coexistence dual-species biofilm coexistence. In conclusion, our study illuminates the competitive and cooperative interactions between these two pathogens, which impact their coexistence and encourage biofilm production. This, in turn, accelerates disease progression and compromises patient health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Microbiology, Egyptian Drug Authority (Former National Organization for Drug Control and Research (NODCAR)), Giza, Egypt. salehneveen@yahoo.com.
- College of Public Health, University of Nebraska Medical Center (UNMC), Omaha, United States. salehneveen@yahoo.com.
- Department of Microbiology, Egyptian Drug Authority (Former National Organization for Drug Control and Research (NODCAR)), Giza, Egypt.
- Department of Animal Production Systems Research, Animal Production Research Institute, Agricultural Research Center, Ministry of Agriculture and Land Reclamation, Giza, Egypt.
- Microbiology and Immunology Department, Faculty of Pharmacy, Beni-Suef University, Beni Suef, 62514, Egypt.
Zitieren
APA
Saleh, N. M., Sudan, E. S. F., Mohamed, S. H., El-Shahed, M. M., Hamouda, R. E., El-Gendy, A. O., & Farag, A. A. (2025). Pathogen Partnerships or Power Struggles? Pseudomonas aeruginosa, and Staphylococcus aureus Dynamics in Cystic Fibrosis. Current Microbiology. https://doi.org/10.1007/s00284-025-04167-4
Vancouver
Saleh NM, Sudan ESF, Mohamed SH, El-Shahed MM, Hamouda RE, El-Gendy AO, et al. Pathogen Partnerships or Power Struggles? Pseudomonas aeruginosa, and Staphylococcus aureus Dynamics in Cystic Fibrosis. Current Microbiology. 2025. doi:10.1007/s00284-025-04167-4
BibTeX
@article{Saleh2025,
author = {Saleh, Neveen M and Sudan, Esraa S F and Mohamed, Sara H and El-Shahed, Maram M and Hamouda, Reda E and El-Gendy, Ahmed Osama and Farag, Ahmed A},
title = {Pathogen Partnerships or Power Struggles? Pseudomonas aeruginosa, and Staphylococcus aureus Dynamics in Cystic Fibrosis},
journal = {Current Microbiology},
year = {2025},
doi = {10.1007/s00284-025-04167-4}
}
EUVIMED